Does pharmacological treatment of depression in people with a primary brain tumour bring any benefits? A Cochrane Review summary with commentary
- 17 June 2022
- journal article
- review article
- Published by IOS Press in NeuroRehabilitation
- Vol. 50 (4), 501-503
- https://doi.org/10.3233/nre-228019
Abstract
BACKGROUND: Persons with primary brain tumour can suffer from depression. Depression may hinder rehabilitation intervention leading to further deterioration of patient’s health and functioning. OBJECTIVE: The Cochrane Review aimed to assess the effecKeywords
This publication has 3 references indexed in Scilit:
- Pharmacological treatment of depression in people with a primary brain tumourEmergencias, 2020
- Frequency, Clinical Associations, and Longitudinal Course of Major Depressive Disorder in Adults With Cerebral GliomaJournal of Clinical Oncology, 2011
- The relationships between depression and brain tumorsJournal of Neuro-Oncology, 2009